Comparative analysis of the X-ray structures of HIV-1 and HIV-2 proteases in complex with CGP 53820, a novel pseudosymmetric inhibitor.Priestle, J.P., Fassler, A., Rosel, J., Tintelnot-Blomley, M., Strop, P., Grutter, M.G.
(1995) Structure 3: 381-389
- PubMed: 7613867
- DOI: https://doi.org/10.1016/s0969-2126(01)00169-1
- Primary Citation of Related Structures:
- PubMed Abstract:
The human immunodeficiency virus (HIV) is the causative agent of acquired immunodeficiency syndrome (AIDS). Two subtypes of the virus, HIV-1 and HIV-2, have been characterized. The protease enzymes from these two subtypes, which are aspartic acid proteases and have been found to be essential for maturation of the infectious particle, share about 50% sequence identity. Differences in substrate and inhibitor binding between these enzymes have been previously reported.
Department of Core Drug Discovery Technologies, Pharma Research, Ciba-Geigy Ltd., Basel, Switzerland.